Platinum china trial demonstrates positive outcomes for the BOSTON SCIENTIFIC PROMUS ELEMENTâ„¢ STENT

Platinum china trial demonstrates positive outcomes for the BOSTON SCIENTIFIC PROMUS ELEMENTâ„¢ STENT

[at noodls] – Mar 21, 2013 Results Revealed at CIT 2013 Beijing (March 21, 2013) – Boston Scientific Corporation (NYSE: BSX) reported clinical endpoint data from the PLATINUM China clinical trial evaluating the safety … more

View todays social media effects on BSX

View the latest stocks trending across Twitter. Click to view dashboard

See who Boston is hiring next, click here to view

Share this post